During the past decade, Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI)" #1 collaborator was "Centre Hospitalier Universitaire Vaudois" with 2 trials as a collaborator, "International AIDS Vaccine Initiative" with 2 trials as a collaborator, "MRC/UVRI and LSHTM Uganda Research Unit" with 2 trials as a collaborator, "Auro Vaccines LLC" with 1 trials as a collaborator and "Entebbe General Hospital" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI)" are "HIV Infections" (2 trials), "HIV/AIDS" (2 trials), "Foreskin HIV Susceptibility" (1 trials), "HIV" (1 trials) and "Schistosomiasis Mansoni" (1 trials). Many other conditions were trialed in "Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI)" in a lesser frequency.

Most popular intervention types in "Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI)" are "Biological" (4 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "AIDSVAX B/E" (1 trials), "Ad35 investigational HIV vaccine" (1 trials), "Ad35-GRIN/ENV" (1 trials), "Adjuvanted GSK investigational HIV vaccine formulation 1" (1 trials) and "Adjuvanted GSK investigational HIV vaccine formulation 2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI)" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI), 4 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".